General Oceans (GENO) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3 operating income was NOK 320m, up 13% YoY (~19% in constant currency); Adjusted EBITA fell to NOK 43m from NOK 49m, with margin down to 13% from 17%.
9M operating income rose 9% to NOK 1,032m; Adjusted EBITA was NOK 186m vs NOK 188m.
Defense and Robotics growth offset weakness in Marine Construction and Sensors; the nine-month market outlook was stable overall.
FY2026 revenue guidance was reduced from NOK 1.5bn to NOK 1.4bn due to an estimated NOK 100m FX impact; sales volumes remained on budget.
Financial highlights
Q3 revenue was NOK 317.4m vs NOK 276.1m; gross profit was NOK 206m vs NOK 197m, while gross margin fell to 64% from 70%.
Q3 operating profit was NOK 19.9m vs NOK 44.3m; net profit was NOK 1.3m vs NOK 36.7m.
9M revenue was NOK 1,022.5m vs NOK 925.8m; net profit was NOK 91.8m vs NOK 139.4m.
9M gross profit was NOK 695m vs NOK 630m; gross margin was 67%, while Adjusted EBITA margin was 18% vs 20%.
Q3 Adjusted EBITA was NOK 43m vs NOK 49m; the bridge included NOK 8m from MRV, NOK -8m underlying performance and NOK -6m FX.
Outlook and guidance
FY2026 revenue guidance is NOK 1.4bn, reduced by NOK 100m due to FX; full-year sales volumes remain in line with budget.
Five new products are planned for 2027, including four based on new hardware architectures spanning Sensors and Robotics.
Four internally funded development projects launched in H2 2026 across Sensors and Robotics.
Nortek resource changes are expected to reduce costs by NOK 27.5m in 2027.
Medium-term targets include a 20% EBITA margin, CapEx of 4% of revenue, working capital of 15–20% of revenue, ROCE above 30%, and net debt/EBITDA of 1.0–2.0x.
Latest events from General Oceans
- Q2 2026 revenue up 22% YoY, robotics excelled, and the group remains debt-free post-IPO.GENO
Q2 2026 - Q1 2026: Revenue down 5% on FX, gross margin up, Robotics growth, IPO boosts cash.GENO
Q1 2026 - Revenue up 18.3% to NOK 957.1m; all brands forecast profitable in 2025.GENO
Q4 2024 - Record revenue and profit growth in 2025, with strong outlook and IPO preparations underway.GENO
Q4 2025